Literature DB >> 7832244

Drug abuse treatment experience and HIV risk behaviors among active drug injectors in Ohio.

H A Siegal1, R G Carlson, R S Falck, J Wang.   

Abstract

This study compares the sociodemographic characteristics and human immunodeficiency virus (HIV) risk behaviors of injection drug users who had received drug abuse treatment in the previous 5 years and those who had not received treatment. The National AIDS Demonstration Research Program database provided 2001 structured interviews, representing Cleveland, Columbus, Cincinnati, and Dayton, Ohio. About 43% of the subjects reported having received treatment in the previous 5 years. Length of involvement with drugs, more frequent injection, more legal problems, and higher levels of HIV risk behaviors were associated with a history of treatment. Incorporating HIV risk reduction education in drug abuse treatment is an urgent priority.

Entities:  

Mesh:

Year:  1995        PMID: 7832244      PMCID: PMC1615275          DOI: 10.2105/ajph.85.1.105

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  AIDS and the social relations of intravenous drug users.

Authors:  S R Friedman; D C Des Jarlais; C E Sterk; J L Sotheran; S Tross; J Woods; M Sufian; A Abdul-Quader
Journal:  Milbank Q       Date:  1990       Impact factor: 4.911

Review 2.  Target groups for preventing AIDS among intravenous drug users: 2. The "hard" data studies.

Authors:  Don C Des Jarlais; Samuel R Friedman; Cathy Casriel
Journal:  J Consult Clin Psychol       Date:  1990-02

3.  Role of drug-abuse treatment in limiting the spread of AIDS.

Authors:  R L Hubbard; M E Marsden; E Cavanaugh; J V Rachal; H M Ginzburg
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

4.  Reducing the risk of AIDS through methadone maintenance treatment.

Authors:  J C Ball; W R Lange; C P Myers; S R Friedman
Journal:  J Health Soc Behav       Date:  1988-09

5.  Factors which differentiate cocaine users in treatment from nontreatment users.

Authors:  D D Chitwood; P C Morningstar
Journal:  Int J Addict       Date:  1985-03

Review 6.  Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research.

Authors:  J Ward; S Darke; W Hall; R Mattick
Journal:  Br J Addict       Date:  1992-03

7.  Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users.

Authors:  R C Stephens; T E Feucht; S W Roman
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

8.  Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.

Authors:  D M Novick; H Joseph; T S Croxson; E A Salsitz; G Wang; B L Richman; L Poretsky; J B Keefe; E Whimbey
Journal:  Arch Intern Med       Date:  1990-01

Review 9.  Methadone treatment and acquired immunodeficiency syndrome.

Authors:  J R Cooper
Journal:  JAMA       Date:  1989 Sep 22-29       Impact factor: 56.272

10.  HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.

Authors:  H A Siegal; R G Carlson; R Falck; L Li; M A Forney; R C Rapp; K Baumgartner; W Myers; M Nelson
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

View more
  2 in total

Review 1.  Drug abuse treatment as AIDS prevention.

Authors:  D S Metzger; H Navaline; G E Woody
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

2.  Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles.

Authors:  Catherine L O'Grady; Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.